Skip to main content
Contribution to Book
Interrogating Metabolism in Brain Cancer
Magnetic Resonance Imaging Clinics of North America (2016)
  • Travis Salzillo, The University of Texas MD Anderson Cancer Center
  • Jingzhe Hu, University of Texas MD Anderson Cancer Center
  • Linda Nguyen, The University of Texas MD Anderson Cancer Center
  • Nicholas Whiting, Rowan University
  • Jaehyuk Lee, The University of Texas MD Anderson Cancer Center
  • Joseph Weygand, The University of Texas MD Anderson Cancer Center
  • Prasanta Dutta, The University of Texas MD Anderson Cancer Center
  • Shivanand Pudakalakatti, The University of Texas MD Anderson Cancer Center
  • Niki Zacharias Millward, University of Texas MD Anderson Cancer Center
  • Seth Gammon, The University of Texas MD Anderson Cancer Center
  • Frederick F Lang, The University of Texas MD Anderson Cancer Center
  • Amy B Heimberger, The University of Texas MD Anderson Cancer Center
  • Pratip Bhattacharya, University of Texas MD Anderson Cancer Center
Abstract
Many existing and emerging techniques of interrogating metabolism in brain cancer are at an early stage of development. A few clinical trials that employ these techniques are in progress in patients with brain cancer to establish the clinical efficacy of these techniques. It is likely that in vivo metabolomics and metabolic imaging is the next frontier in brain cancer diagnosis and assessing therapeutic efficacy.
Publication Date
2016
Editor
M. Clinton
Publisher
Elsevier Publishing
DOI
10.1016/j.mric.2016.07.003
Citation Information
Travis Salzillo, Jingzhe Hu, Linda Nguyen, Nicholas Whiting, et al.. "Interrogating Metabolism in Brain Cancer" Magnetic Resonance Imaging Clinics of North America Vol. 24 (2016) p. 687 - 703
Available at: http://0-works.bepress.com.library.simmons.edu/nicholas-whiting/16/